Release date: June 10, 2025
Expiration date: June 9, 2028
Estimated Time of Completion: 1 hour
Description
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
Learning Objectives
- Describe contemporary guidelines for starting low-dose aspirin for the primary prevention of atherosclerotic cardiovascular disease.
- Explain how low-dose aspirin guidance changes in patients as they age.
- Critically appraise the use of low-dose aspirin among patients with established cardiovascular disease and / or taking systemic anticoagulation.
Target Audience
Directed to primary care physicians including family practitioners and internists.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Your credit will be reported to the ABIM within 30 days of claiming credit.
ABS MOC: Successful completion of this CME activity, enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
ABA MOC: This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
Activity Director and Faculty
Activity Directors
Anthony Fernandez, MD, PhD
Director, Medical and Inpatient Dermatology
W.D. Steck Chair of Clinical Dermatology
Co-Director, Center for Continuing Education
Cleveland Clinic
Cleveland, OH
Steven Kawczak, PhD, CHCP, FACEHP
Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine of CWRU
Co-Director, Center for Continuing Education
Director, Center for International Medical Education
Staff, Center for Educational Resources
Education Institute
Cleveland Clinic
Cleveland, OH
Faculty
Luke J. Laffin MD
Co-Director, Center for Blood Pressure Disorders
Department of Cardiovascular Medicine
Cleveland Clinic
Cleveland, OH
Carolina Pires Zingano, MD
Cleveland Clinic
Cleveland, OH
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing
Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
Anthony P Fernandez, MD, PhD |
Biogen Inc., Boehringer Ingelheim, UCB, Inc. |
Consulting |
Bristol-Myers Squibb Co., Mallinckrodt Inc., Novartis |
Consulting
Teaching and Speaking |
Pfizer, Inc. |
Other activities from which remuneration is received or expected: awarded a grant to fund a medical dermatology fellowship position
Research: PI |
Alexion, Castle Biosciences |
Research: Principal Investigator |
Abbvie Pharmaceuticals |
Consulting
Advisor or review panel participant
Teaching and Speaking |
Kyowa Kirin |
Teaching and Speaking |
Luke J. Laffin, MD |
Astrazeneca Pharmaceuticals |
Research (Ended: 12/31/2024) |
Arrowhead, Crisper Therapeutics, Eli Lilly, Mineralys Therapeutics |
Research |
Medtronic |
Consulting |
Idorsia Pharmaceuticals Ltd. |
Consulting (Ended: 12/31/2024) |
ReCor Medical |
Consulting
Teaching and Speaking |
Cardiometabolic Health Congress |
Teaching and Speaking (Ended: 12/31/2024) |
Gordy Health |
Advisor or review panel participant (Ended: 07/01/2024) |
LucidAct Health |
Advisor or review panel participant (Ended: 12/31/2024) |
All other persons in control of content have no relevant financial relationships.
This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education.